Sanofi has moved to bolster its vaccines business by reaching a deal to buy London, UK-based biotech Vicebio, which was formed to produce improved, more potent shots that are simpler to manufacture.

Novartis has reached an agreement to buy Regulus Therapeutics and its experimental therapy for autosomal dominant polycystic kidney disease (ADPKD) for $800 million upfront in a deal that could have a ...

Companies such as Meta, Amazon, and Coinbase have said they're trimming staff this year. Many firms have cited the rise of AI as a reason they need fewer staff. See the list of companies letting ...

Dive into The Register's online archive of incisive tech news reporting, features, and analysis dating back to 1998 ...